Markets Courses Calendar News Analysis & Opinion Brokers Advertise

Loading

Loading…

Learn to Lead.

Trading-education courses, live markets, financial news, the economic calendar and broker reviews — in one trusted hub.

Learn

All Courses
Forex
Stocks
Crypto

Markets

Indices
Financial News
Economic Calendar
Analysis & Opinion
Broker Reviews

Account

Log in
Sign up
My Learning
About Us
Contact Us
Advertise

Legal

Terms & Conditions
Privacy Policy
Refund & Cancellation
Risk Disclaimer
Cookie Policy

© 2026 Academiya. All rights reserved.

Terms Privacy Refund Risk Disclaimer Cookies

Risk warning: Trading and investing carry risk of loss. Educational content on Academiya is for learning purposes only and is not financial advice. Market data may be delayed.

Markets today

Financial news

The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.

Updated 13 Jul, 01:30 am

NASDAQ:IONSfmp·9 Jul

Market Plunge: Ionis Pharmaceuticals (NASDAQ: IONS) Leads Biotech Stock Decline Amid Clinical Trial Failure

Ionis Pharmaceuticals (NASDAQ: IONS) Leads Major Stock Decliners After Phase 3 Trial Miss Clinical Trial Setback: Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) experienced the largest decline after a Phase 3 study of eplontersen failed to meet its primary endpoint. Analyst Downgrade

NASDAQ:NTICfmp·9 Jul

Northern Technologies International Corporation (NASDAQ:NTIC) Navigates Mixed Q3 2026 Financial Landscape

Revenue Growth: Northern Technologies International Corporation (NASDAQ:NTIC) reported record revenue of $24.22 million , a 12.6% increase year-over-year, exceeding analyst expectations for its corrosion prevention and bioplastic solutions. Profitability Challenges: Despite stron

NYSE:JPMfmp·9 Jul

JPMorgan Chase & Co. (NYSE: JPM) Q2 2026 Earnings Preview and Market Outlook

Positive Growth Outlook: Wall Street estimates earnings per share (EPS) of $5.52 ( 11.3% increase) and revenue of $51.06 billion ( 8.4% increase). Positive Analyst Sentiment: The consensus EPS estimate has been revised upward by 1.3% , with increased price targets from UBS and Bo

NYSE:EPACfmp·9 Jul

Enerpac Tool Group (NYSE: EPAC) Leads Peers in Capital Efficiency and Value Creation

Enerpac Tool Group (NYSE: EPAC) demonstrates exceptional capital efficiency with an ROIC significantly higher than its WACC , indicating strong value creation . Many of Enerpac Tool Group's competitors, such as Helios Technologies, Inc. (NASDAQ: HLIO) and National Bank Holdings C

NASDAQ:FLYfmp·9 Jul

Firefly Aerospace Inc. (NASDAQ: FLY) Soars: Growth, Lunar Missions, and Analyst Confidence

Firefly Aerospace is transitioning from a development-stage startup to a high-growth provider, marked by nearly 135% revenue growth in its latest fiscal year. The company's specialized offerings, including the Alpha launch vehicle and Blue Ghost lunar delivery, are key drivers fo

NASDAQ:TOIfmp·9 Jul

The Oncology Institute (NASDAQ:TOI) Poised for Growth with Strong Financial Outlook and Analyst Confidence

Analyst firm BTIG reiterated a "Buy" rating for The Oncology Institute and increased its price target, signaling strong confidence in the company's future. The Oncology Institute successfully completed a significant financial restructuring, repaying an $86.00 million convertible

NASDAQ:IONSfmp·9 Jul

Ionis Pharmaceuticals (NASDAQ: IONS) Price Target Set Amidst Clinical Trial Setback

Jefferies set a new price target of $90.00 for Ionis Pharmaceuticals, suggesting a potential upside of 39.56% . Ionis Pharmaceuticals and AstraZeneca's late-stage trial for Wainua (eplontersen) failed to meet its primary goal for transthyretin-mediated amyloid cardiomyopathy (ATT

NYSE:GDfmp·9 Jul

General Dynamics (NYSE:GD) Stock Performance: Jefferies Boosts Price Target Amid Strong Earnings

Jefferies' "Buy" rating and increased price target signal strong analyst confidence in General Dynamics (NYSE:GD). General Dynamics ' stock performance is robust, hitting a 52-week high and outperforming its sector and industry. The company demonstrates solid financial health wit

NASDAQ:SMPLfmp·9 Jul

Simply Good Foods (SMPL) Q3 Beats, Sales Down, Impairment Hit

The Simply Good Foods Company (NASDAQ: SMPL) Beats Quarterly Estimates Despite Sales Decline and Impairment Loss Adjusted Earnings Beat: The Simply Good Foods Company reported adjusted diluted earnings of $0.42 per share , exceeding the analyst consensus estimate of $0.35. Revenu

NASDAQ:IONSfmp·9 Jul

Ionis Pharmaceuticals (NASDAQ:IONS) Stock Plunges on Disappointing Clinical Trial Results

Ionis Pharmaceuticals (NASDAQ:IONS) experienced a significant stock decline following the failure of its drug Wainua in a late-stage clinical trial. Analyst firm Needham reiterated a Buy rating but lowered its price target for Ionis from $105.00 to $86.00 . The market reaction sa

NYSE:KOfmp·9 Jul

The Coca-Cola Company (NYSE:KO): A Dividend King's Steady Growth and Analyst Outlook

The Coca-Cola Company (NYSE:KO) is a renowned "Dividend King" and "blue-chip stock," consistently rewarding shareholders with increased dividend payments for 64 consecutive years. Despite hitting an all-time high, an analyst set a conservative price target of $83.00 , suggesting

NYSE:MMMfmp·9 Jul

3M (NYSE: MMM) Stock Analysis: Wolfe Research Raises Price Target Amid Strong Performance

Wolfe Research reaffirmed its Outperform rating for 3M, raising its price target to $189.00 from $182.00 . The company's Safety and Industrial segment demonstrated strong performance with a 3.2% year-over-year increase in adjusted organic sales and improved operating margin. 3M p

NASDAQ:SSRMfmp·9 Jul

SSR Mining (NASDAQ:SSRM) Shifts Strategy, Analysts See Upside

SSR Mining (NASDAQ:SSRM) is strategically refocusing its operations on the Americas, divesting non-core assets to mitigate geopolitical risk. The company significantly strengthened its financial position by selling its 80% stake in the Çöpler Mine for $1.49 billion in cash. Marke

NASDAQ:BYRNfmp·9 Jul

Byrna Technologies Inc. (NASDAQ:BYRN) Navigates Q2 Earnings Miss Amidst Strategic Expansion in Personal Defense Market

Byrna Technologies Inc. is strategically expanding its product offerings in the personal defense market through the acquisition of HERO Defense Systems, aiming to introduce smaller, lower-priced products. The company reported a significant financial downturn in its fiscal second

NYSE:SCHWfmp·9 Jul

Charles Schwab (NYSE: SCHW) Stock Analysis: Price Target Update and Investor Sentiment

Barclays analyst adjusted the price target for Charles Schwab (NYSE: SCHW) , suggesting a potential 19.39% upside . The company demonstrates strong earnings performance , consistently beating analyst estimates. High retail investor engagement , as indicated by the Schwab Trading

NASDAQ:FIVEfmp·9 Jul

Five Below (NASDAQ:FIVE) Stock Analysis: Growth Potential Amidst Mixed Analyst Ratings

Five Below (NASDAQ:FIVE) faces mixed analyst sentiment, with RBC Capital issuing a 'Sector Perform' rating while Zacks maintains a 'Strong Buy' recommendation. The specialty retailer demonstrates strong growth potential, highlighted by a Growth Score of A and an attractive PEG ra

NYSE:BLKfmp·9 Jul

BlackRock (NYSE: BLK) Stock: Insider Sale Contrasts with Bullish Analyst Projections and ETF Expansion

A recent insider sale of BlackRock Inc. (NYSE: BLK) shares occurred just before its Q2 results. Analysts from UBS and Zacks Investment Research maintain a positive outlook on BlackRock, citing attractive valuation, strong ETF demand, and anticipated earnings growth. BlackRock is

NASDAQ:PEPfmp·9 Jul

PepsiCo (NASDAQ:PEP) Q2 Earnings Beat Estimates, Stock Dips on Cautious Outlook

PepsiCo reported strong Q2 earnings per share (EPS) of $2.20 , narrowly surpassing analyst estimates of $2.19 . The global food and beverage giant's revenue reached $24.18 billion , exceeding projections and marking its fourth consecutive quarter of beating consensus estimates. D

1…282930…62

From Investing.com

Earnings call transcript: Camping World trims outlook after Q2 revenue miss, shares fallInvesting.com33m ago
CRH Q2 2026 slides: record performance, $8.5B Arcosa dealInvesting.com33m ago
FTAI Aviation Q2 2026 slides: power contract, production surge amid earnings missInvesting.com34m ago
Earnings call transcript: Solstice Advanced Materials tops Q2 2026 EPS forecastInvesting.com34m ago
Ferrari CEO says Luce orders "in line with expectations"Investing.com34m ago
Earnings call transcript: Core Laboratories misses Q2 2026 EPS forecastInvesting.com34m ago
Bucher H1 2026 presentation: mixed results as EBIT margin falls to 7.1%Investing.com34m ago
PennyMac Financial Services stock hits 52-week low at 75.74 USDInvesting.com34m ago
SCOR Q2 2026 slides: ROE hits 19% as reinsurer beats targetsInvesting.com35m ago
Brightstar Lottery stock hits 52-week low at 10.19 USDInvesting.com35m ago

Headlines provided by Investing.com

Go deeper

Turn headlines into edge

General
LEARN TO TRADE LIKE A PRO Master Institutional Trading
$2505.0
General
LEARN TO TRADE LIKE A PRO(R) Master Institutional Trading
$150

Browse all courses